The WACC of BioMaxima SA (BMX.WA) is 10.2%.
Range | Selected | |
Cost of equity | 9.10% - 12.40% | 10.75% |
Tax rate | 19.70% - 48.80% | 34.25% |
Cost of debt | 4.00% - 25.50% | 14.75% |
WACC | 7.9% - 12.6% | 10.2% |
Category | Low | High |
Long-term bond rate | 5.5% | 6.0% |
Equity market risk premium | 6.3% | 7.3% |
Adjusted beta | 0.56 | 0.81 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 9.10% | 12.40% |
Tax rate | 19.70% | 48.80% |
Debt/Equity ratio | 0.25 | 0.25 |
Cost of debt | 4.00% | 25.50% |
After-tax WACC | 7.9% | 12.6% |
Selected WACC | 10.2% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BMX.WA:
cost_of_equity (10.75%) = risk_free_rate (5.75%) + equity_risk_premium (6.80%) * adjusted_beta (0.56) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.